Javier Narvaez
Overview
Explore the profile of Javier Narvaez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
224
Citations
2030
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Narvaez J, Aguilar-Coll M, Roig-Kim M, Palacios-Olid J, Maymo-Paituvi P, de Daniel Bisbe L, et al.
Autoimmun Rev
. 2025 Mar;
:103804.
PMID: 40089094
Objective: To evaluate the efficacy, safety, and tolerability of antifibrotic agents, nintedanib and pirfenidone, in the treatment of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Methods: A systematic literature review was...
2.
Martin-Gutierrez A, Molina-Collada J, Dominguez-Alvaro M, Melero-Gonzalez R, Fernandez-Fernandez E, Silva-Diaz M, et al.
Rheumatology (Oxford)
. 2025 Feb;
PMID: 39918980
Objective: To determine the prevalence and predictive factors of cerebrovascular accidents (CVA) in giant cell arteritis (GCA). Methods: ARTESER is a large Spanish multicentre registry including patients with GCA from...
3.
Vidal-Montal P, Narvaez J, Fulladosa X, Mitjavila F, Capdevila O, Torras J, et al.
Lupus Sci Med
. 2025 Jan;
12(1.
PMID: 39832909
Objective: To investigate the rate and factors influencing renal relapse (RR) in proliferative lupus nephritis (LN) patients who discontinued immunosuppressive therapy (IST), as well as the long-term renal outcomes following...
4.
Narvaez J, Palacios-Olid J, Garcia de Yebenes M, Holgado S, Olive A, Casafont-Sole I, et al.
J Clin Med
. 2025 Jan;
14(1.
PMID: 39797367
To investigate the prevalence and clinical spectrum of atypical or non-classical complications in adult-onset Still's disease (AOSD) beyond macrophage activation syndrome (MAS) and to identify factors linked to their occurrence....
5.
Cobo-Ibanez T, Castellvi I, Pros A, Dominguez-Alvaro M, Nuno-Nuno L, Martinez-Barrio J, et al.
Arthritis Res Ther
. 2025 Jan;
27(1):5.
PMID: 39780297
Objective: To evaluate the main outcomes of disease activity and their association with other measures of activity, damage, and quality of life in patients with idiopathic inflammatory myopathy (IIM) according...
6.
Molina-Collada J, Dominguez-Alvaro M, Melero-Gonzalez R, De Miguel E, Silva-Diaz M, Valero Jaimes J, et al.
Arthritis Res Ther
. 2025 Jan;
27(1):4.
PMID: 39773317
Objectives: To compare mortality rates between GCA patients and the general population in Spain, and to identify associated factors influencing mortality. Methods: ARTESER, a multicenter registry by the Spanish Society...
7.
Narvaez J, Vidal-Montal P, Sanchez-Rodriguez I, Sabate-Llobera A, Cortes-Romera M, Palacios-Olid J, et al.
Arthritis Res Ther
. 2024 Dec;
26(1):230.
PMID: 39732686
Objective: To investigate differences in arterial involvement patterns on F-FDG PET-CT between predominant cranial and isolated extracranial phenotypes of giant cell arteritis (GCA). Methods: A retrospective review of F-FDG PET-CT...
8.
Narvaez J, Aguilar-Coll M, Vicens-Zygmunt V, Alegre J, Bermudo G, Molina-Molina M
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685534
: Interstitial lung disease (ILD) is one of the most severe complications of rheumatoid arthritis (RA). Real-world data on antifibrotic treatment are needed. Our objective was to evaluate the real-world...
9.
Narvaez J, Dominguez M, Agirregoikoa E, Mendizabal J, Abasolo L, Lluch J, et al.
Rheumatology (Oxford)
. 2024 Nov;
PMID: 39589919
Objetive: To evaluate the frequency and timing of sustained drug-free remission (SDFR) in patients with giant cell arteritis (GCA) and to identify potential predictive factors of this outcome. Methods: Retrospective...
10.
Estrada P, Narvaez J, Moya P, Roig-Vilaseca D, Camacho O, Navarro V, et al.
Eur J Rheumatol
. 2024 Nov;
11(2):33-38.
PMID: 39576031
Background: Giant cell arteritis (GCA) is a heterogeneous disease with diverse clinical presentations and varying degrees of severity. This study aimed to assess the incidence of 3 clinical subsets in...